Reuters logo
Cleveland Clinic blood-test patents invalid, Federal Circuit affirms
June 16, 2017 / 10:37 PM / 5 months ago

Cleveland Clinic blood-test patents invalid, Federal Circuit affirms

The Cleveland Clinic’s discovery of a way to assess cardiovascular health through a blood test rather than heart surgery might have been groundbreaking, but it’s not eligible for a patent, a federal appeals court held Friday.

The 3-0 decision by the U.S. Court of Appeals for the Federal Circuit affirmed last year’s ruling by a federal judge in Ohio, dismissing Cleveland Clinic’s patent-infringement suit against True Health Diagnostics.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2sI8dQ1

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below